Prescribing intelligence for therapies relating to the gastro-intestinal system
The gastro-intestinal system is comprised of organs from the mouth to the anus and so this section covers a wide variety of therapies including, but not limited to therapies for irritable bowel syndrome (IBS), diarrhoea, constipation, peptic ulcers, pancreatic enzyme deficiency and haemorrhoids. Please click here for live data for ulcerative colitis and Crohn’s disease prescribing.
The number of prescription items for treatments relating to the gastro-intestinal system has been increasing each year, from 60 million prescription items in 2007 to 99 million in 2017. Net ingredient cost has varied over this period however spend is now 4% lower than in 2007. Antisecretory drugs and mucosal protectants constitute almost two thirds of the prescription items in this section.
The RxIndex to the right gives an up-to-date snapshot of the most frequently-prescribed brands in one of GPrX’s gastro-intestinal system sub-categories.